Open Access Green as soon as Postprint is submitted to ZB.
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.
Nanotox. 6, 36-46 (2012)
It is of urgent need to identify the exact physico-chemical characteristics, which allow maximum uptake and accumulation in secondary target organs of nanoparticulate drug delivery systems after oral ingestion. We administered radio labelled gold nanoparticles in different sizes (1.4 - 200nm) with negative surface charge and 2.8nm nanoparticles with opposite surface charges by intra-oesophageal instillation into healthy adult female rats. The quantitative amount of the particles in organs, tissues and excrements was measured after 24 hours by gamma-spectroscopy. The highest accumulation in secondary organs was mostly found for 1.4nm particles; the negatively charged particles were accumulated mostly more than positively charged particles. Importantly, 18nm particles show a higher accumulation in brain and heart compared to other sized particles. No general rule accumulation can be made so far. Therefore, specialised drug delivery systems via the oral route have to be individually designed, depending on the respective target organ.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
3.880
1.057
225
279
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Gold NP; Gavage; Absorption; Gastro-intestinal tract; In vivo biodistribution
Language
english
Publication Year
2012
Prepublished in Year
2011
HGF-reported in Year
2011
ISSN (print) / ISBN
1743-5390
e-ISSN
1743-5404
Journal
Nanotoxicology
Quellenangaben
Volume: 6,
Issue: 1,
Pages: 36-46
Publisher
Informa Healthcare
Publishing Place
London
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)
PSP Element(s)
G-505000-002
PubMed ID
21309618
WOS ID
WOS:000299094000003
Scopus ID
83955165727
Erfassungsdatum
2011-05-04